The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
Cholesterol in brain disease: sometimes determinant and frequently implicated
Open accessAbstract
Cholesterol is essential for neuronal physiology, both during development and in the adult life: as a major component of cell membranes and precursor of steroid hormones, it contributes to the regulation of ion permeability, cell shape, cell-cell interaction, and transmembrane signaling. Consistently, hereditary diseases with mutations in cholesterol-related genes result in impaired brain function during early life. In addition, defects in brain cholesterol metabolism may contribute to neurological syndromes, such as Alzheimer's disease (AD), Huntington's disease (HD), and Parkinson's disease (PD), and even to the cognitive deficits typical of the old age. In these cases, brain cholesterol defects may be secondary to disease-causing elements and contribute to the functional deficits by altering synaptic functions. In the first part of this review, we will describe hereditary and non-hereditary causes of cholesterol dyshomeostasis and the relationship to brain diseases. In the second part, we will focus on the mechanisms by which perturbation of cholesterol metabolism can affect synaptic function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As statins were designed to act primarily by inhibiting cholesterol synthesis, their beneficial effects in the Mecp2-deficient mouse presumably reflect other mechanisms of action given that brain cholesterol synthesis is already moderately suppressed in these mice (Orth and Bellosta, 2012; Martin et al., 2014).”
From Suppression of brain cholesterol synthesis in male Mecp2-deficient mice is age dependent and not accompanied by a concurrent change in the rate of fatty acid synthesis (2017) · cites this paper as Martin et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Myelin contains the majority (>80%) of the brain’s free cholesterol”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Martín et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Nevertheless, diet-derived cholesterol cannot cross the BBB and cannot compensate the low cholesterol level in the brain [3,24].”
From Loss of Mevalonate/Cholesterol Homeostasis in the Brain: A Focus on Autism Spectrum Disorder and Rett Syndrome (2019) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“The most severe mutations of this gene cause fetal or newborn death, while less severe variants cause developmental defects in specific organs such as facial and cranial malformations, hypospadia or complete gonadal absence [24].”
From Loss of Mevalonate/Cholesterol Homeostasis in the Brain: A Focus on Autism Spectrum Disorder and Rett Syndrome (2019) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Cholesterol has been implied in the production and clearance of beta amyloid [24].”
From Loss of Mevalonate/Cholesterol Homeostasis in the Brain: A Focus on Autism Spectrum Disorder and Rett Syndrome (2019) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Disruption of cholesterol homeostasis has also been shown to perturb cell-autonomous and non-cell-autonomous functions, including inhibition of crucial signaling pathways and cellular crosstalk (Bjorkhem and Meaney, 2004; Martin et al., 2014).”
From Sterol dysregulation in Smith–Lemli–Opitz syndrome causes astrocyte immune reactivity through microglia crosstalk (2022) · cites this paper as Martin et al., 2014
The cited source says what the claim attributes to it.
In the citing paper
“These data reinforce the previously well-established link between brain cholesterol metabolism dysfunction and AD pathogenesis [42], by pointing to PCSK9 as an additional contributor to the neuronal degeneration occurring in this disease.”
From PCSK9 affects astrocyte cholesterol metabolism and reduces neuron cholesterol supplying in vitro: potential implications in Alzheimer’s disease (2022) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
Lipid rafts as a membrane-organizing principle
Lingwood, D., & Simons, K. (2010) · Science · doi:10.1126/science.1174621 · Cited by 4,417
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
CNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711
Self-citationSchmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Cellular cholesterol trafficking and compartmentalization
Ikonen, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2336 · Cited by 1,506
Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,408
Cholesterol Modification of Hedgehog Signaling Proteins in Animal Development
Porter, J. A., Young, K. E., & Beachy, P. A. (1996) · Science · doi:10.1126/science.274.5285.255 · Cited by 1,360
Revitalizing membrane rafts: new tools and insights
Simons, K., & Gerl, M. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2977 · Cited by 1,268
Membrane fusion and exocytosis.
Jahn, R., & Südhof, T. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.863 · Cited by 1,253
Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance
Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,242 · cited 1×
“Moreover, Apoe4 has different properties than other Apoe isoforms, which may impair the glia-to-neuron transport of cholesterol, reduce myelin, and diminish the capacity to degrade the toxic amyloid peptide [94–100].”
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway
Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J.-L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3137 · Cited by 1,233
Vanier, M. T. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-16 · Cited by 1,222
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168
A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11041 · Cited by 1,134
Dietschy, J. M., & Turley, S. D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400004-jlr200 · Cited by 1,095
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050
Brain Cholesterol: Long Secret Life Behind a Barrier
Björkhem, I., & Meaney, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000120374.59826.1b · Cited by 1,044
Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., Troncoso, J. C., & Mattson, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305799101 · Cited by 1,008
The Postsynaptic Architecture of Excitatory Synapses: A More Quantitative View
Sheng, M., & Hoogenraad, C. C. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060805.160029 · Cited by 1,003
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950
Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ
Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. J., & Mangelsdorf, D. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.266 · Cited by 946
Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 932
Lipid raft microdomains and neurotransmitter signalling
Allen, J., Halverson-Tamboli, R. A., & Rasenick, M. M. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn2059 · Cited by 880
A review of Parkinson's disease
Davie, C. A. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn013 · Cited by 858
Teratogen-Mediated Inhibition of Target Tissue Response to Shh Signaling
Cooper, M. K., Porter, J. A., Young, K. E., & Beachy, P. A. (1998) · Science · doi:10.1126/science.280.5369.1603 · Cited by 848
Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics
de la Torre, J. C. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00683-0 · Cited by 834
Lloyd‐Evans, E., Morgan, A. J., He, X., Smith, D. A., Elliot-Smith, E., Sillence, D. J., Churchill, G. C., Schuchman, E. H., Galione, A., & Platt, F. M. (2008) · Nature Medicine · doi:10.1038/nm.1876 · Cited by 832
Protein-Lipid Interplay in Fusion and Fission of Biological Membranes
Chernomordik, L., & Kozlov, M. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161504 · Cited by 799
Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D., & Weisgraber, K. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47945-8 · Cited by 714
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Lang, T., Bruns, D., Wenzel, D., Riedel, D., Holroyd, P., Thiele, C., & Jahn, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2202 · Cited by 686
cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain
Lund, E. G., Guileyardo, J. M., & Russell, D. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7238 · Cited by 668
Kwon, H. J., Abi-Mosleh, L., Wang, M. L., Deisenhofer, J., Goldstein, J. L., Brown, M. S., & Infante, R. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.049 · Cited by 636
Lipid Rafts in the Maintenance of Synapses, Dendritic Spines, and Surface AMPA Receptor Stability
Hering, H., Lin, C.-C., & Sheng, M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03262.2003 · Cited by 622
ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
Kanekiyo, T., Xu, H., & Bu, G. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.045 · Cited by 608
Radhakrishnan, A., Ikeda, Y., Kwon, H. J., Brown, M. S., & Goldstein, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700899104 · Cited by 556
Plant, K., Pelkey, K. A., Bortolotto, Z. A., Morita, D., Terashima, A., McBain, C. J., Collingridge, G. L., & Isaac, J. T. R. (2006) · Nature Neuroscience · doi:10.1038/nn1678 · Cited by 542
Cholesterol metabolism in neurons and astrocytes
Pfrieger, F. W., & Ungerer, N. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.002 · Cited by 500
Self-citationCholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles
Thiele, C., Hannah, M. J., Fahrenholz, F., & Huttner, W. B. (2000) · Nature Cell Biology · doi:10.1038/71366 · Cited by 498
Newman, A. B., Fitzpatrick, A. L., Lopez, O., Jackson, S., Lyketsos, C., Jagust, W., Ives, D., DeKosky, S. T., & Kuller, L. H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53360.x · Cited by 492
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
Patterson, M. C., Hendriksz, C. J., Walterfang, M., Sedel, F., Vanier, M. T., & Wijburg, F. A. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.012 · Cited by 473
Malformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins
Humphreys, D. T., Carver, J. A., Easterbrook‐Smith, S. B., & Wilson, M. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6875 · Cited by 463
Targeting Rab GTPases to distinct membrane compartments
Pfeffer, S. R., & Aivazian, D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1500 · Cited by 462
Cholesterol homeostasis and function in neurons of the central nervous system
Pfrieger, F. W. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3018-7 · Cited by 453
Self-citationDavidson, C. D., Ali, N. F., Micsenyi, M. C., Stephney, G. W., Renault, S., Dobrenis, K., Ory, D. S., Vanier, M. T., & Walkley, S. U. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006951 · Cited by 449
Sparks, D. L., Scheff, S. W., Hunsaker, J. C., Liu, H., Landers, T., & Gross, D. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1044 · Cited by 443
Tall, A. R. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01898.x · Cited by 436
The influence of cholesterol on phospholipid membrane curvature and bending elasticity
Chen, Z., & Rand, R. P. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78067-6 · Cited by 433
Chamberlain, L. H., Burgoyne, R. D., & Gould, G. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091502398 · Cited by 432
The role of receptor diffusion in the organization of the postsynaptic membrane
Choquet, D., & Triller, A. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1077 · Cited by 427
The role of sterols in plant growth and development
Schaller, H. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00047-4 · Cited by 415
Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain
Björkhem, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01725.x · Cited by 397
A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.
Pentchev, P. G., Comly, M. E., Kruth, H. S., Vanier, M. T., Wenger, D. A., Patel, S., & Brady, R. O. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8247 · Cited by 396
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
Wolozin, B. L., Wang, S. W., Li, N.-C., Lee, A. F., Lee, T. A., & Kazis, L. E. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-20 · Cited by 391
Martins, I. J., Hone, E., Foster, J. K., Sünram-Lea, S. I., Gnjec, A., Fuller, S. J., Nolan, D., Gandy, S. E., & Martins, R. N. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001854 · Cited by 388
Lütjohann, D., Papassotiropoulos, A., Björkhem, I., Locatelli, S., Bagli, M., Oehring, R. D., Schlegel, U. S., Jessen, F., Rao, M. L., von Bergmann, K., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32052-6 · Cited by 378
Non-vesicular lipid transport by lipid-transfer proteins and beyond
Lev, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2971 · Cited by 372
Statin‐Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature
Wagstaff, L. R., Mitton, M. W., McLendon-Arvik, B., & Doraiswamy, P. M. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.7.871.32720 · Cited by 366
Vascular pathology in the aged human brain
Grinberg, L. T., & Thal, D. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0652-7 · Cited by 345
Porter, F. D., Scherrer, D. E., Lanier, M. H., Langmade, S. J., Molugu, V., Gale, S. E., Olzeski, D., Sidhu, R., Dietzen, D. J., Fu, R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001417 · Cited by 343
Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
Vance, J. E. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010124 · Cited by 342
Synaptic Plasticity and AMPA Receptor Trafficking
Malenka, R. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.001 · Cited by 333
Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron
Goritz, C., Mauch, D. H., & Pfrieger, F. W. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.02.006 · Cited by 330
Self-citationNeuronal membrane cholesterol loss enhances amyloid peptide generation
Abad‐Rodríguez, J., Ledesma, M. D., Craessaerts, K., Perga, S., Medina, M., Delacourte, A., Dingwall, C., Strooper, B. D., & Dotti, C. G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404149 · Cited by 329
Self-citationRole of cholesterol in synapse formation and function
Pfrieger, F. W. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00024-5 · Cited by 325
Self-citationCholesterol 24-Hydroxylase: an enzyme of cholesterol turnover in the brain
Russell, D. W., Halford, R. W., Ramirez, D. M. O., Shah, R., & Kotti, T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.072407.103859 · Cited by 317
Li, Y., Wang, H., Muffat, J., Cheng, A. W., Orlando, D. A., Lovén, J., Kwok, S., Feldman, D., Bateup, H. S., Gao, Q., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.09.001 · Cited by 315
Liscum, L., Ruggiero, R. M., & Faust, J. R. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.5.1625 · Cited by 307
Greeve, I., Hermans‐Borgmeyer, I., Brellinger, C., Kasper, D., Gómez‐Isla, T., Behl, C., Levkau, B., & Nitsch, R. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07345.2000 · Cited by 300
Liver X receptors in the central nervous system: From lipid homeostasis to neuronal degeneration
Wang, L., Schuster, G. U., Hultenby, K. R., Zhang, Q., Andersson, S., & Gustafsson, J.-Α. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172510899 · Cited by 298
Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease
Valenza, M., Rigamonti, D., Goffredo, D., Zuccato, C., Fenu, S., Jamot, L., Strand, A., Tarditi, A., Woodman, B., Racchi, M., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3355-05.2005 · Cited by 298
Svennerholm, L. T., Boström, K. B., Jungbjer, B., & Olsson, L. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051802.x · Cited by 294
Pravastatin and cognitive function in the elderly. Results of the PROSPER study
Trompet, S., Vliet, P., Craen, A. J. M., Jolles, J., Buckley, B. M., Murphy, M. B., Ford, I., Macfarlane, P. W., Sattar, N., Packard, C. J., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5271-7 · Cited by 291
The Arabidopsis DIMINUTO/DWARF1 Gene Encodes a Protein Involved in Steroid Synthesis
Klahre, U., Noguchi, T., Fujioka, S., Takatsuto, S., Yokota, T., Nomura, T., Yoshida, S., & Chua, N. (1998) · The Plant Cell · doi:10.1105/tpc.10.10.1677 · Cited by 290
Atherosclerosis and AD: Analysis of data from the US National Alzheimer’s Coordinating Center
Honig, L. S., Kukull, W., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000150886.50187.30 · Cited by 284
Laufs, U., Gertz, K. R., Dirnagl, U., Böhm, M., Nickenig, G., & Endres, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02649-5 · Cited by 279
Roher, A. E., Weiss, N., Kokjohn, T. A., Kuo, Y.-M., Kalback, W., Anthony, J., Watson, D., Luehrs, D. C., Sue, L., Walker, D., et al. (2002) · Biochemistry · doi:10.1021/bi026173d · Cited by 279
Paul, S. M., Doherty, J., Robichaud, A. J., Belfort, G. M., Chow, B. Y., Hammond, R., Crawford, D. C., Linsenbardt, A. J., Shu, H., Izumi, Y., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2619-13.2013 · Cited by 276
Consequences of NPC1 and NPC2 loss of function in mammalian neurons
Walkley, S. U., & Suzuki, K. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.08.011 · Cited by 274
SYMPOSIUM REVIEW: Lipid microdomains and the regulation of ion channel function
Dart, C. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.191585 · Cited by 273
Brain cholesterol turnover required for geranylgeraniol production and learning in mice
Kotti, T. J., Ramirez, D. M. O., Pfeiffer, B. E., Huber, K. M., & Russell, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600316103 · Cited by 270
Jiang, X., Sidhu, R., Porter, F. D., Yanjanin, N. M., Speak, A. O., Vruchte, D. T., Platt, F. M., Fujiwara, H., Scherrer, D. E., Zhang, J., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d015735 · Cited by 270
Lipid Compositions of Different Regions of the Human Brain During Aging
Söderberg, M. P., Edlund, C., Kristensson, K., & Dallner, G. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01889.x · Cited by 269
Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain
Heverin, M., Meaney, S., Lütjohann, D., Diczfalusy, U., Wahren, J., & Björkhem, I. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500024-jlr200 · Cited by 269
Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
Reed, B., Villeneuve, S., Mack, W., DeCarli, C., Chui, H. C., & Jagust, W. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5390 · Cited by 267
Cerebrovascular Effects of Apolipoprotein E: Implications for Alzheimer Disease
Zlokovic, B. V. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2152 · Cited by 263
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
Cramer, C., Haan, M. N., Galea, S., Langa, K. M., & Kalbfleisch, J. D. (2008) · Neurology · doi:10.1212/01.wnl.0000319647.15752.7b · Cited by 255
The CNS renin-angiotensin system
Halbach, O. V. B. U., & Albrecht, D. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0190-8 · Cited by 251
Ko, D. C., Gordon, M. D., Jin, J. Y., & Scott, M. P. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.3.601 · Cited by 244
Ordovas, J. M., Litwack-Klein, L., Wilson, P. W., Schaefer, M. M., & Schaefer, E. J. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38690-9 · Cited by 238
A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome
Buchovecky, C. M., Turley, S. D., Brown, H. M., Kyle, S. M., McDonald, J. G., Liu, B., Pieper, A. A., Huang, W., Katz, D. M., Russell, D. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2714 · Cited by 234
Svennerholm, L., Boström, K., & Jungbjer, B. (1997) · Acta Neuropathologica · doi:10.1007/s004010050717 · Cited by 232
24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia
Papassotiropoulos, A., Lütjohann, D., Bagli, M., Locatelli, S., Jessen, F., Buschfort, R., Ptok, U., Björkhem, I., von Bergmann, K., & Heun, R. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00050-4 · Cited by 231
GILL, S., Chow, R., & Brown, A. J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.04.002 · Cited by 229
Cholesterol homeostasis in neurons and glial cells
Vance, J. E., Hayashi, H., & Karten, B. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.01.005 · Cited by 225
Molander‐Melin, M., Blennow, K., Bogdanović, N., Dellheden, B., Månsson, J., & Fredman, P. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02849.x · Cited by 224
Niemann–Pick C2 (NPC2) and intracellular cholesterol trafficking
Storch, J., & Xu, Z. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.02.001 · Cited by 216
Hudry, E., Dam, D. V., Kulik, W., Deyn, P. P. D., Stet, F. S., Ahouansou, O., Benraiss, A., Delacourte, A., Bougneres, P. F., Aubourg, P. R., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.175 · Cited by 214
Gong, J.-S., Kobayashi, M., Hayashi, H., Zou, K., Sawamura, N., Fujita, S. C., Yanagisawa, K., & Michikawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203934200 · Cited by 214
Bogdanović, N., Brétillon, L., Lund, E. G., Diczfalusy, U., Lannfelt, L., Winblad, B. G., Russell, D. W., & Björkhem, I. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02277-7 · Cited by 213
Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs)
Holopainen, J. M., Saarikoski, J., Kinnunen, P. K. J., & Järvelä, I. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02530.x · Cited by 211
Cholesterol reduction impairs exocytosis of synaptic vesicles
Linetti, A., Fratangeli, A., Taverna, E., Valnegri, P., Francolini, M., Cappello, V., Matteoli, M., Passafaro, M., & Rosa, P. (2010) · Journal of Cell Science · doi:10.1242/jcs.060681 · Cited by 209
Smith–Lemli–Opitz syndrome: Phenotype, natural history, and epidemiology
Nowaczyk, M. J. M., & Irons, M. (2012) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31343 · Cited by 208
Cholesterol binding to ion channels
Levitan, I., Singh, D. K., & Rosenhouse‐Dantsker, A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00065 · Cited by 207
Donkin, J. J., Stukas, S., Hirsch-Reinshagen, V., Namjoshi, D., Wilkinson, A., May, S., Chan, J., Fan, J., Collins, J., & Wellington, C. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108100 · Cited by 200
Lipids on Trial: The Search for the Offending Metabolite in Niemann-Pick type C Disease
Lloyd‐Evans, E., & Platt, F. M. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01032.x · Cited by 199
Regulation of cellular response to oncogenic and oxidative stress by Seladin-1
Wu, C., Miloslavskaya, I., Demontis, S., Maestro, R., & Galaktionov, K. I. (2004) · Nature · doi:10.1038/nature03173 · Cited by 195
Dynamic Transbilayer Lipid AsymmetryPreprint
Gerrit van, M. E. E. R. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004671 · Cited by 193
Mason, R. P., Shoemaker, W. J., Shajenko, L., Chambers, T. E., & Herbette, L. G. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90116-f · Cited by 191
Mondal, M., Mesmin, B., Mukherjee, S., & Maxfield, F. R. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0785 · Cited by 191
Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 190
Cholesterol Level and Statin Use in Alzheimer Disease
Shepardson, N. E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.242 · Cited by 190
Tsaousidou, M. K., Ouahchi, K., Warner, T. T., Yang, Y., Simpson, M. A., Laing, N. G., Wilkinson, P. A., Madrid, R. E., Patel, H., Hentati, F., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.001 · Cited by 188
ATP-binding cassette transporter AI and its role in HDL formation
Lee, J., & Parks, J. S. (2005) · Current Opinion in Lipidology · doi:10.1097/00041433-200502000-00005 · Cited by 187
Vanier, M. T. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00041-1 · Cited by 183
Cholesterol facilitates the native mechanism of Ca2+-triggered membrane fusion
Churchward, M. A., Rogasevskaia, T. P., Höfgen, J., Bau, J. T., & Coorssen, J. R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02601 · Cited by 178
Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse
Quan, G., Xie, C., Dietschy, J. M., & Turley, S. D. (2003) · Developmental Brain Research · doi:10.1016/j.devbrainres.2003.09.015 · Cited by 177
Ghosh, A., Roy, A., Matras, J., Brahmachari, S., Gendelman, H. E., & Pahan, K. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4144-09.2009 · Cited by 175
Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin
Vance, J. E., & Karten, B. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r047837 · Cited by 174
Beel, A. J., Sakakura, M., Barrett, P. J., & Sanders, C. R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.008 · Cited by 170
Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y., & Huang, Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0033-12.2012 · Cited by 170
The role of seladin‐1/DHCR24 in cholesterol biosynthesis, APP processing and Aβ generation in vivo
Crameri, A., Biondi, E., Kuehnle, K., Lütjohann, D., Thelen, K., Perga, S., Dotti, C. G., Nitsch, R. M., Ledesma, M. D., & Mohajeri, M. H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600938 · Cited by 170
Self-citationGallet, A., Ruel, L., Staccini-Lavenant, L., & Thérond, P. P. (2006) · Development · doi:10.1242/dev.02212 · Cited by 169
Lipids and Cholesterol as Regulators of Traffic in the Endomembrane System
Lippincott‐Schwartz, J., & Phair, R. D. (2010) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.093008.131357 · Cited by 168
Fukumoto, H., Deng, A., Irizarry, M. C., Fitzgerald, M. L., & Rebeck, G. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209085200 · Cited by 166
Valenza, M., Leoni, V., Karasinska, J. M., Petricca, L., Fan, J., Carroll, J., Pouladi, M. A., Fossale, E., Nguyen, H. P., Riess, O., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0917-10.2010 · Cited by 166
Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease
Yao, J., Ho, D. J., Calingasan, N. Y., Pipalia, N. H., Lin, M. T. S., & Beal, M. F. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121239 · Cited by 162
Genetic variations and treatments that affect the lifespan of the NPC1 mouse
Liu, B., Li, H., Repa, J. J., Turley, S. D., & Dietschy, J. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700525-jlr200 · Cited by 160
Liang, Y., Lin, S., Beyer, T. P., Zhang, Y., Wu, X., Bales, K. R., DeMattos, R. B., May, P. C., Li, S. D., Jiang, X., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02183.x · Cited by 160
Cholesterol Accumulates in Senile plaques of Alzheimer Disease patients and in Transgenic APPswMice
Mori, T., Paris, D., Town, T., Rojiani, A. M., Sparks, D. L., Delledonne, A., Crawford, F., Abdullah, L. I., Humphrey, J. A., Dickson, D. W., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.778 · Cited by 159
Xie, C., Lund, E. G., Turley, S. D., Russell, D. W., & Dietschy, J. M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300164-jlr200 · Cited by 159
Niemann–Pick Type C Mutations Cause Lipid Traffic Jam
Liscum, L. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010304.x · Cited by 154
Desmosterol and DHCR24: Unexpected new directions for a terminal step in cholesterol synthesis
Zerenturk, E. J., Sharpe, L. J., Ikonen, E., & Brown, A. J. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.09.002 · Cited by 152
Karten, B., Vance, D. E., Campenot, R. B., & Vance, J. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01220.x · Cited by 149
HDL and LDL cholesterol significantly influence β-cell function in type 2 diabetes mellitus
Kruit, J. K., Brunham, L. R., Verchere, C. B., & Hayden, M. R. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328339387b · Cited by 148
Hayashi, H., Campenot, R. B., Vance, D. E., & Vance, J. E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5471-06.2007 · Cited by 146
Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1)
Ohyama, Y., Meaney, S., Heverin, M., Ekström, L., Brafman, A., Shafir, M., Andersson, U., Olin, M., Eggertsen, G., Diczfalusy, U., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505179200 · Cited by 146
Control of the postsynaptic membrane viscosity
Renner, M., Choquet, D., & Triller, A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4445-08.2009 · Cited by 145
Chamberlain, L. H., & Gould, G. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206936200 · Cited by 143
Genetics of Alzheimer's disease: new evidences for an old hypothesis?
Lambert, J., & Amouyel, P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.002 · Cited by 141
CYP7B1: One Cytochrome P450, Two Human Genetic Diseases, and Multiple Physiological Functions
Stiles, A. R., McDonald, J. G., Bauman, D. R., & Russell, D. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.042168 · Cited by 139
How do heart disease and stroke become risk factors for Alzheimer's disease?
de la Torre, J. C. (2006) · Neurological Research · doi:10.1179/016164106x130362 · Cited by 139
Karasinska, J. M., Rinninger, F., Lütjohann, D., Ruddle, P., Franciosi, S., Kruit, J. K., Singaraja, R. R., Hirsch-Reinshagen, V., Fan, J., Brunham, L. R., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4741-08.2009 · Cited by 133
The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells
Kölsch, H., Lütjohann, D., Tulke, A., Björkhem, I., & Rao, M. L. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01274-8 · Cited by 133
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains
Ledesma, M. D., Abad‐Rodríguez, J., Galván, C. A., Biondi, E., Navarro, P., Delacourte, A., Dingwall, C., & Dotti, C. G. (2003) · EMBO Reports · doi:10.1038/sj.embor.7400021 · Cited by 133
Self-citationStatins: Multiple neuroprotective mechanisms in neurodegenerative diseases
Wang, Q., Yan, J., Chen, X., Li, J., Yang, Y., Weng, J., Deng, C., & Yenari, M. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2010.04.006 · Cited by 130
Lehtinen, S., Lehtimäki, T. J., Sisto, T., Salenius, J., Nikkilä, M. T., Jokela, H., Koivula, T. A., Ebeling, F. T., & Ehnholm, C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05469-y · Cited by 129
Cholesterol oxidation products in the vascular remodeling due to atherosclerosis
Poli, G., Sottero, B., Gargiulo, S., & Leonarduzzi, G. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.02.003 · Cited by 126
Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus
Frank, C., Rufini, S., Tancredi, V., Forcina, R., Grossi, D., & D’Arcangelo, G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.019 · Cited by 126
Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia
Zambón, D., Quintana, M., Mata, P., Alonso, R., Benavent, J., Cruz-Sánchez, F., Gich, J., Pocoví, M., Civeira, F., Capurro, S., et al. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.08.015 · Cited by 125
Wong, W. B., Lin, V. W., Boudreau, D. M., & Devine, E. B. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3381 · Cited by 124
Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis
Schüle, R., Siddique, T., Deng, H., Yang, Y., Donkervoort, S. C., Hansson, M. E. A., Madrid, R. E., Siddique, N., Schöls, L. J., & Björkhem, I. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002543 · Cited by 124
Trushina, E. V., Singh, R. D., Dyer, R. B., Cao, S., Shah, V. H., Parton, R. G., Pagano, R. E., & McMurray, C. T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl434 · Cited by 123
Ottinger, E., Kao, M., Carrillo-Carrasco, N., Yanjanin, N., Shankar, R., Janssen, M., Brewster, M., Scott, I., Xu, X., Cradock, J., et al. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026613666131127160118 · Cited by 121
Membrane Lipids in the Aging Human Brain
Svennerholm, L. T., Boström, K., Helander, C. G., & Jungbjer, B. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03466.x · Cited by 119
Karu, K., Hornshaw, M. P., Woffendin, G., Bodin, K., Hámberg, M., Alvélius, G., Sjövall, J., Turton, J. A., Wang, Y., & Griffiths, W. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600497-jlr200 · Cited by 116
Koob, A. O., Ubhi, K. K., Paulsson, J. F., Kelly, J. W., Rockenstein, E. M., Mante, M., Adame, A., & Masliah, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.015 · Cited by 113
Apolipoprotein J/Clusterin Prevents a Progressive Glomerulopathy of Aging
Rosenberg, M. E., Girton, R. A., Finkel, D., Chmielewski, D., Barrie, A. M., Witte, D. P., Zhu, G., Bissler, J. J., Harmony, J. A. K., & Aronow, B. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1893-1902.2002 · Cited by 112
Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice
Kitaguchi, H., Tomimoto, H., Ihara, M., Shibata, M., Uemura, K., Kalaria, R. N., Kihara, T., Asada-Utsugi, M., Kinoshita, A., & Takahashi, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.078 · Cited by 108
Spontaneous fusion of phosphatidylcholine small unilamellar vesicles in the fluid phase
Lentz, B. R., Carpenter, T. J., & Alford, D. R. (1987) · Biochemistry · doi:10.1021/bi00391a026 · Cited by 108
DeBarber, A. E., Eroğlu, Y., Merkens, L. S., Pappu, A. S., & Steiner, R. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941100189x · Cited by 108
Cholesterol synthesis rate in human hippocampus declines with aging
Thelen, K. M., Falkai, P., Bayer, T. A., & Lütjohann, D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.034 · Cited by 107
Mulder, M. T., Ravid, R., Swaab, D. F., de Kloet, E. R., Haasdijk, E. D., Julk, J., van der Boom, J., & Havekes, L. M. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00012 · Cited by 107
ABCA1 influences neuroinflammation and neuronal death
Karasinska, J. M., de Haan, W., Franciosi, S., Ruddle, P., Fan, J., Kruit, J. K., Stukas, S., Lütjohann, D., Gutmann, D. H., Wellington, C. L., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.018 · Cited by 104
Cholesterol Loss Enhances TrkB Signaling in Hippocampal Neurons Aging in Vitro
Martín, M. G., Perga, S., Trovò, L., Rasola, A., Holm, P. C., Rantamäki, T., Harkany, T., Ċastrén, E., Chiara, F., & Dotti, C. G. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0897 · Cited by 103
Self-citationAmyloid precursor protein controls cholesterol turnover needed for neuronal activity
Pierrot, N., Tyteca, D., D’Auria, L., Dewachter, I., Gailly, P. L., Hendrickx, A., Tasiaux, B., Haylani, L. E., Muls, N., N’Kuli, F., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202215 · Cited by 103
Constitutive hippocampal cholesterol loss underlies poor cognition in old rodents
Martín, M. G., Ahmed, T., Korovaichuk, A., Venero, C., Menchón, S. A., Salas, I. H., Munck, S., Herreras, Ó., Balschun, D., & Dotti, C. G. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303711 · Cited by 102
Self-citationIncreased cholesterol in Aβ-positive nerve terminals from Alzheimer's disease cortex
Gylys, K. H., Fein, J. A., Yang, F., Miller, C. A., & Cole, G. M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.018 · Cited by 100
Cholesterol loss during glutamate‐mediated excitotoxicity
Sodero, A. O., Vriens, J., Ghosh, D., Stegner, D., Brachet, A., Pallotto, M., Sassoé‐Pognetto, M., Brouwers, J. F. H. M., Helms, J. B., Nieswandt, B., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.31 · Cited by 100
Self-citationZhiyou, C., Yong, Y., Shanquan, S., Jun, Z., Liangguo, H., Ling, Y., & Li, J. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9899-y · Cited by 96
The vascular contribution to Alzheimer's disease
Altman, R., & Rutledge, J. C. (2010) · Clinical Science · doi:10.1042/cs20100094 · Cited by 93
Glutamate receptor dynamics and protein interaction: Lessons from the NMDA receptor
Bard, L., & Groc, L. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.05.009 · Cited by 93
Lipid rafts at postsynaptic sites: distribution, function and linkage to postsynaptic density
Suzuki, T. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00080-9 · Cited by 92
Sterol metabolism disorders and neurodevelopment—an update
Kanungo, S., Soares, N. S., He, M., & Steiner, R. D. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1114 · Cited by 89
Maioli, S., Båvner, A., Ali, Z., Heverin, M., Ismail, M.-A.-M., Puerta, E., Olin, M., Saeed, A., Shafaati, M., Parini, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068534 · Cited by 85
Mutational spectrum of Smith–Lemli–Opitz syndrome
Waterham, H. R., & Hennekam, R. C. M. (2012) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31346 · Cited by 82
Howard, B. V., Gidding, S. S., & Liu, K. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009711 · Cited by 81
Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors
Futter, M., Diekmann, H., Schoenmakers, E., Sadiq, O., Chatterjee, K., & Rubinsztein, D. C. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066399 · Cited by 80
Effects of the cholesterol‐lowering compound methyl‐β‐cyclodextrin in models of α‐synucleinopathy
Bar‐On, P., Rockenstein, E. M., Adame, A., Ho, G. J., Hashimoto, M., & Masliah, E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04017.x · Cited by 78
Fabelo, N., Martín, M. V., Marín, R., Santpere, G., Aso, E., Ferrer, I., & Díaz, M. L. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31826be03c · Cited by 76
Self-citationSynapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease
Bordji, K., Becerril-Ortega, J., & Buisson, A. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.029 · Cited by 75
Vasilevko, V., Passos, G. F., Quiring, D., Head, E., Kim, R. C., Fisher, M., & Cribbs, D. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05786.x · Cited by 74
The role of APP proteolytic processing in lipid metabolism
Grimm, M. O. W., Rothhaar, T. L., & Hartmann, T. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2975-6 · Cited by 70
Frank, C., Giammarioli, A. M., Pepponi, R., Fiorentini, C., & Rufini, S. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.113 · Cited by 70
Koide, T., Hayata, T., & Cho, K. W. Y. (2006) · Development · doi:10.1242/dev.02393 · Cited by 69
Low cell cholesterol levels increase NFκB activity through a p38 MAPK-dependent mechanism
Calleros, L., Lasa, M., Toro, M. J., & Chiloeches, A. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.012 · Cited by 68
Alterations of cholesterol precursor levels in Alzheimer's disease
Kölsch, H., Heun, R., Jessen, F., Popp, J., Hentschel, F., Maier, W., & Lütjohann, D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.001 · Cited by 67
Sodero, A. O., Trovò, L., Iannilli, F., Veldhoven, P. P. V., Dotti, C. G., & Martín, M. G. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07079.x · Cited by 62
Self-citationCortical Injury Increases Cholesterol 24S Hydroxylase (Cyp46) Levels in the Rat Brain
Cartagena, C. M., Ahmed, F. A. K. M., Burns, M. P., Pajoohesh‐Ganji, A., Pak, D. T. S., Faden, A. I., & Rebeck, G. W. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0444 · Cited by 62
Low hippocampal PI(4,5)P2 contributes to reduced cognition in old mice as a result of loss of MARCKS
Trovò, L., Ahmed, T., Callaerts‐Vegh, Z., Buzzi, A., Bagni, C., Chuah, M., VandenDriessche, T., D’Hooge, R., Balschun, D., & Dotti, C. G. (2013) · Nature Neuroscience · doi:10.1038/nn.3342 · Cited by 61
Self-citationThe Therapeutic Potential of Statins in Neurological Disorders
Rajanikant, G. K., Zemke, D., Kassab, M., & Majid, A. (2006) · Current Medicinal Chemistry · doi:10.2174/092986707779313462 · Cited by 60
Joshi, H., Fakes, M. G., & Serajuddin, A. T. M. (1999) · Pharmacy and Pharmacology Communications · doi:10.1211/146080899128734820 · Cited by 58
Mailman, T. M., Hariharan, M., & Karten, B. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07474.x · Cited by 57
Mateos, L., Ismail, M.-A.-M., Gil-Bea, F. J., Schüle, R., Schöls, L. J., Heverin, M., Folkesson, R., Björkhem, I., & Cedazo-Mı́nguez, Á. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236877 · Cited by 56
Leaky synapses: Regulation of spontaneous neurotransmission in central synapses
Wasser, C. R., & Kavalali, E. T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.028 · Cited by 55
Cited by
Sorted by citations
TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge
Nugent, A. A., Lin, K., van Lengerich, B., Lianoglou, S., Przybyla, L., Davis, S. S., Llapashtica, C., Wang, J., Kim, D. J., Xia, D., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.007 · Cited by 745
There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D. H. W., Mueller, S., Miller, T., & Miller, C. C. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.008 · Cited by 439
Schultz, B. G., Patten, D. K., & Berlau, D. J. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0110-3 · Cited by 235
A Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Li, R.-Y., Qin, Q., Yang, H.-C., Wang, Y.-Y., Mi, Y.-X., Yin, Y.-S., Wang, M., Yu, C.-J., & Tang, Y. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00542-y · Cited by 204
Metadata
- Authors
- Martín, M. G., Pfrieger, F., & Dotti, C. G.
- Affiliations
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Centre National de la Recherche Scientifique (FR)
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Martín, Mauricio G
- Pfrieger, Frank
- Dotti, Carlos G
- Venue
- The EMBO Reports
- Published
- 2014-09-15
- Volume
- 15
- Issue
- 10
- Pages
- 1036-1052
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC4253844
- OpenAlex
- W2027703774
- Cited by
- 304
- References
- 235
- Citations by year
- 2026: 18 · 2025: 28 · 2024: 31 · 2023: 42 · 2022: 40 · 2021: 27 · 2020: 30 · 2019: 24 · 2018: 25 · 2017: 12 · 2016: 16 · 2015: 10
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Lirias (submittedVersion)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- brain cholesterol, cholesterol metabolism, Alzheimer's disease, Huntington's disease, Parkinson's disease, cognitive impairment, synaptic function, ion permeability, transmembrane signaling
- MeSH terms
- Alzheimer Disease, Cell Membrane, Cholesterol, Humans, Huntington Disease, Mutation, Neurons, Parkinson Disease, Gonadal Steroid Hormones, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
